Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies,
are at a high risk of developing hepatocellular carcinoma (HCC). Even after complete HCC …

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver responsible
for an increasing number of cancer-related deaths, especially in developing economies of …

Hepatitis C virus infection is a major cause of hepatocellular carcinoma worldwide.
Interferon has been the major antiviral treatment, yielding viral clearance in approximately …

Background Nucleos (t) ide analogues (NUC s) for chronic hepatitis B treatment achieve
high rates of viral suppression and are generally well tolerated. Entecavir (ETV) and …

Cirrhosis is a diffuse pathophysiological state of the liver considered to be the final stage of
various liver injuries, characterized by chronic necroinflammatory and fibrogenetic …

Screening of undocumented migrants or refugees for hepatitis B virus (HBV), hepatitis C
virus (HCV) and human immunodeficiency virus (HIV) infections has been offered free of …

Background: Liver disease severity must be determined before treatment of chronic hepatitis
C (CHC). We evaluated the diagnostic performance of the APRI and FIB-4 scores compared …

The goal of antiviral therapy is to improve the quality of life and survival of patients with
chronic hepatitis B (CHB) by halting the progression to cirrhosis, end‐stage liver disease or …

Chronic hepatitis C virus (HCV) infection is an infection that affects over 71 million people
worldwide that primarily leads to significant morbidity and mortality through its predisposition …

Background This retrospective study at a single center aimed to evaluate the role of the red
blood cell distribution width (RDW)-to-platelet ratio and other laboratory indices associated …